Quality of Life Research

, Volume 5, Issue 5, pp 496–502

Guidelines for reporting results of quality of life assessments in clinical trials

Authors

  • M. Staquet
    • Faculty of Medicine (DCS)Brussels Free University
  • R. Berzon
    • Bayer Pharmaceuticals
  • D. Osoba
    • British Columbia Cancer Agency
    • University of British Columbia
  • D. Machin
    • MRC Cancer Trials Office
Research Papers

DOI: 10.1007/BF00540022

Cite this article as:
Staquet, M., Berzon, R., Osoba, D. et al. Qual Life Res (1996) 5: 496. doi:10.1007/BF00540022

Abstract

Clinical trials involving quality of life measurement published in the literature suffer from important weaknesses due to the lack of information on numerous topics. The psychometric properties of the instruments are often lacking as well as data on the number of patients treated and analyzed. The handling of missing data is rarely documented. In order to facilitate the reporting of trials and the evaluation of published results, this article proposes a set of general guidelines for the reporting of clinical trials which include a quality of life assessment. A checklist designed to assist authors is appended.

Key words

Clinical trialsguidelineshealth-related quality of lifequality of lifereporting

Copyright information

© Rapid Science Publishers 1996